by | Oct 31, 2019 | Colonna, Marco
— Target: NKp44 is a novel triggering surface molecular specifcially expressed by activated natural killer cells.
Notes: Clone name 448.189 Marco Colonna, MD
Inventors generated NKp44 monocolonal antibodies by immunizing mice with a NKp44-human crystallizable fragment (Fc) fusion protein. The antibodies have been used to study innate and adaptive immune responses.
Publication: Paradoxic inhibition of human natural interferon-producing cells by the activ…
by | Oct 22, 2019 | Diamond, Michael
— Target: Dengue Virus
Notes: PrM-12 and -22
by | Oct 22, 2019 | Diamond, Michael
— Primary Inventor: Michael S. Diamond, MD
Target: Venezuelan Equine Encephalitis Virus
by | Oct 22, 2019 | Colonna, Marco
— Target: Cluster of Differentiation 172g protein, a.k.a. Signal Regulatory Protein Alpha and Beta.
Notes: Clone name is 148.
by | Oct 22, 2019 | Colonna, Marco
— Target: Cluster of Differentiation 155 protein, a.k.a. Poliovirus Receptor.
Notes: Clone name is SKII.4.